Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study

J Am Acad Dermatol. 2021 Dec;85(6):1657-1660. doi: 10.1016/j.jaad.2020.12.073. Epub 2021 Jan 10.

Affiliations

¹ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York. Electronic address: hee.kim@mountsinai.org.
² Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York.
³ Department of Biostatistics, University at Buffalo, Buffalo, New York.

PMID: 33440217
DOI: 10.1016/j.jaad.2020.12.073

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Humans
Pilot Projects
Skin Pigmentation
Thalidomide / analogs & derivatives
Thalidomide / therapeutic use
Treatment Outcome
Ultraviolet Therapy*
Vitiligo* / drug therapy
Vitiligo* / radiotherapy

Substances

Thalidomide
apremilast